Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Shares Issued (2022 - 2024)

Day One Biopharmaceuticals (DAWN) has disclosed Shares Issued for 3 consecutive years, with -$19.0 million as the latest value for Q4 2024.

  • Quarterly Shares Issued changed N/A to -$19.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$19.0 million through Sep 2025, down 190.9% year-over-year, with the annual reading at $1.9 million for FY2024, N/A changed from the prior year.
  • Shares Issued for Q4 2024 was -$19.0 million at Day One Biopharmaceuticals, down from $20.6 million in the prior quarter.
  • The five-year high for Shares Issued was $161.6 million in Q2 2022, with the low at -$161.4 million in Q3 2023.
  • Average Shares Issued over 3 years is $190600.0, with a median of $186000.0 recorded in 2024.
  • Peak annual rise in Shares Issued hit 112.74% in 2024, while the deepest fall reached 99.8% in 2024.
  • Over 3 years, Shares Issued stood at -$2.1 million in 2022, then tumbled by 7761.67% to -$161.4 million in 2023, then skyrocketed by 88.21% to -$19.0 million in 2024.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$19.0 million, $20.6 million, and $324000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.